
Teladoc (TDOC) Stock Forecast & Price Target
Teladoc (TDOC) Analyst Ratings
Bulls say
Teladoc Health Inc. has demonstrated a rebound in key metrics with BetterHelp achieving sequential membership growth after five quarters of declines, indicating potential stabilization and recovery within its user base. The Integrated Care segment added 800 clients in January, reflecting ongoing demand and expansion within the market. Additionally, the company reported a significant improvement in GAAP EPS to ($0.25), attributed to effective expense management, and sees promising growth potential from a burgeoning market and an increase in paid memberships, supported by the expansion of virtual care services.
Bears say
Teladoc Health is facing a negative outlook as its total revenue declined by 3.0% year-over-year, primarily due to a significant contraction in the BetterHelp segment, which saw a revenue drop of 9.5%. Additionally, the company’s guidance indicates expectations of continued decline in BetterHelp revenue and slight margin compression, further compounding concerns around profitability. The prolonged decrease in BetterHelp users over the last five quarters, coupled with management's cautious stance on user growth, underscores challenges in achieving a rebound in revenue performance.
This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.
Teladoc (TDOC) Analyst Forecast & Price Prediction
Start investing in Teladoc (TDOC)
Order type
Buy in
Order amount
Est. shares
0 shares